EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in non-small cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy

Personalizing medicines has refined the traditional treatments for non-small-cell lung cancer (NSCLC). In the present study, efforts towards personalizing delivery of care based on the status of EGFR and K-RAS mutations, and mRNA expression levels of ERCC1, TUBB3, TYMS, RRM1 and EGFR by choosing app...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Clin Oncol
Main Authors: GUO, NANNAN, ZHANG, WEN, ZHANG, BAOSHI, LI, YINGJIE, TANG, JIAN, LI, SHAOJUN, ZHAO, YINGNAN, ZHAO, YUNLONG, XIA, HUI, YU, CHANGHAI
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2015
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535032/
https://ncbi.nlm.nih.gov/pubmed/26623063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.611
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares